493 related articles for article (PubMed ID: 23742186)
21. Catestatin Enhances Neuropathic Pain Mediated by P2X4 Receptor of Dorsal Root Ganglia in a Rat Model of Chronic Constriction Injury.
Deng Z; Li C; Du E; Liu C; Xia B; Chen H; He Q; Xu C
Cell Physiol Biochem; 2018; 51(2):812-826. PubMed ID: 30463084
[TBL] [Abstract][Full Text] [Related]
22. Extracellular signal-regulated kinase activation in the chronic constriction injury model of neuropathic pain in anaesthetized rats.
Borges GS; Berrocoso E; Ortega-Alvaro A; Mico JA; Neto FL
Eur J Pain; 2013 Jan; 17(1):35-45. PubMed ID: 23055268
[TBL] [Abstract][Full Text] [Related]
23. Glial phosphorylated p38 MAP kinase mediates pain in a rat model of lumbar disc herniation and induces motor dysfunction in a rat model of lumbar spinal canal stenosis.
Ito T; Ohtori S; Inoue G; Koshi T; Doya H; Ozawa T; Saito T; Moriya H; Takahashi K
Spine (Phila Pa 1976); 2007 Jan; 32(2):159-67. PubMed ID: 17224809
[TBL] [Abstract][Full Text] [Related]
24. Role of Ras in ethanol modulation of angiotensin II activated p42/p44 MAP kinase in rat hepatocytes.
Park PH; Aroor AR; Shukla SD
Life Sci; 2006 Nov; 79(25):2357-63. PubMed ID: 16950409
[TBL] [Abstract][Full Text] [Related]
25. Sinomenine alleviates dorsal root ganglia inflammation to inhibit neuropathic pain via the p38 MAPK/CREB signalling pathway.
Wang X; Liu Y; Zhang H; Jin J; Ma Y; Leng Y
Eur J Pharmacol; 2021 Apr; 897():173945. PubMed ID: 33596416
[TBL] [Abstract][Full Text] [Related]
26. Activation of p38 and p42/44 MAP kinase in neuropathic pain: involvement of VPAC2 and NK2 receptors and mediation by spinal glia.
Garry EM; Delaney A; Blackburn-Munro G; Dickinson T; Moss A; Nakalembe I; Robertson DC; Rosie R; Robberecht P; Mitchell R; Fleetwood-Walker SM
Mol Cell Neurosci; 2005 Dec; 30(4):523-37. PubMed ID: 16202621
[TBL] [Abstract][Full Text] [Related]
27. Activation of fibroblast growth factor receptor by axotomy, through downstream p38 in dorsal root ganglion, contributes to neuropathic pain.
Yamanaka H; Obata K; Kobayashi K; Dai Y; Fukuoka T; Noguchi K
Neuroscience; 2007 Nov; 150(1):202-11. PubMed ID: 17905520
[TBL] [Abstract][Full Text] [Related]
28. Ghrelin alleviates neuropathic pain through GHSR-1a-mediated suppression of the p38 MAPK/NF-κB pathway in a rat chronic constriction injury model.
Zhou CH; Li X; Zhu YZ; Huang H; Li J; Liu L; Hu Q; Ma TF; Shao Y; Wu YQ
Reg Anesth Pain Med; 2014; 39(2):137-48. PubMed ID: 24513955
[TBL] [Abstract][Full Text] [Related]
29. The protective effect of resveratrol in the transmission of neuropathic pain mediated by the P2X
Xie J; Liu S; Wu B; Li G; Rao S; Zou L; Yi Z; Zhang C; Jia T; Zhao S; Schmalzing G; Hausmann R; Nie H; Li G; Liang S
Neurochem Int; 2017 Feb; 103():24-35. PubMed ID: 28027922
[TBL] [Abstract][Full Text] [Related]
30. Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain.
Smith MT; Muralidharan A
Expert Opin Ther Targets; 2015 Jan; 19(1):25-35. PubMed ID: 25315162
[TBL] [Abstract][Full Text] [Related]
31. Histamine H4 receptor activation alleviates neuropathic pain through differential regulation of ERK, JNK, and P38 MAPK phosphorylation.
Sanna MD; Stark H; Lucarini L; Ghelardini C; Masini E; Galeotti N
Pain; 2015 Dec; 156(12):2492-2504. PubMed ID: 26270581
[TBL] [Abstract][Full Text] [Related]
32. Effect of tetramethylpyrazine on primary afferent transmission mediated by P2X3 receptor in neuropathic pain states.
Gao Y; Xu C; Liang S; Zhang A; Mu S; Wang Y; Wan F
Brain Res Bull; 2008 Sep; 77(1):27-32. PubMed ID: 18639742
[TBL] [Abstract][Full Text] [Related]
33. Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT(2)) receptor. Effects on neurite outgrowth in NG108-15 cells.
Guimond MO; Wallinder C; Alterman M; Hallberg A; Gallo-Payet N
Eur J Pharmacol; 2013 Jan; 699(1-3):160-71. PubMed ID: 23211679
[TBL] [Abstract][Full Text] [Related]
34. Levo
Dai WL; Bao YN; Fan JF; Li SS; Zhao WL; Yu BY; Liu JH
Reg Anesth Pain Med; 2020 Mar; 45(3):219-229. PubMed ID: 31898581
[TBL] [Abstract][Full Text] [Related]
35. Glial activation in the periaqueductal gray promotes descending facilitation of neuropathic pain through the p38 MAPK signaling pathway.
Ni HD; Yao M; Huang B; Xu LS; Zheng Y; Chu YX; Wang HQ; Liu MJ; Xu SJ; Li HB
J Neurosci Res; 2016 Jan; 94(1):50-61. PubMed ID: 26423029
[TBL] [Abstract][Full Text] [Related]
36. Direct single injection of p38 mitogen-activated protein kinase inhibitor does not affect calcitonin gene-related peptide expression in dorsal root ganglion neurons innervating punctured discs in rats.
Hayashi Y; Ohtori S; Yamashita M; Yamauchi K; Inoue G; Suzuki M; Orita S; Eguchi Y; Ochiai N; Kishida S; Takaso M; Fukui Y; Wakai K; Kuniyoshi K; Ishikawa T; Arai G; Miyagi M; Kamoda H; Aoki Y; Takahashi K
Spine (Phila Pa 1976); 2009 Dec; 34(26):2843-7. PubMed ID: 20010392
[TBL] [Abstract][Full Text] [Related]
37. Respective pharmacological features of neuropathic-like pain evoked by intrathecal BDNF versus sciatic nerve ligation in rats.
M'Dahoma S; Barthélemy S; Tromilin C; Jeanson T; Viguier F; Michot B; Pezet S; Hamon M; Bourgoin S
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2118-30. PubMed ID: 26343858
[TBL] [Abstract][Full Text] [Related]
38. The role of large-conductance, calcium-activated potassium channels in a rat model of trigeminal neuropathic pain.
Liu CY; Lu ZY; Li N; Yu LH; Zhao YF; Ma B
Cephalalgia; 2015 Jan; 35(1):16-35. PubMed ID: 24820887
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons.
Schäfers M; Svensson CI; Sommer C; Sorkin LS
J Neurosci; 2003 Apr; 23(7):2517-21. PubMed ID: 12684435
[TBL] [Abstract][Full Text] [Related]
40. Blockade of peripheral P2Y1 receptors prevents the induction of thermal hyperalgesia via modulation of TRPV1 expression in carrageenan-induced inflammatory pain rats: involvement of p38 MAPK phosphorylation in DRGs.
Kwon SG; Roh DH; Yoon SY; Moon JY; Choi SR; Choi HS; Kang SY; Han HJ; Beitz AJ; Lee JH
Neuropharmacology; 2014 Apr; 79():368-79. PubMed ID: 24333674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
